JOIN US FOR AN EXCLUSIVE ESSILOR® STELLEST EDUCATIONAL EVENT
Advancing Myopia Management in Practice
For event details or to register, click on the location below that you'd like to attend.
 |  |  |  |  |  |
 |  |  | |||
Join us for an exclusive in-person educational event featuring Essilor® Stellest® lenses - the first and only FDA market authorized spectacle lens to slow myopia progression in children*1.
1. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S clinical trial in myopic children aged 6-12 years at initiation of treatment.